259 related articles for article (PubMed ID: 15940362)
21. Neutralization of interleukin-11 activity decreases osteoclast formation and increases cancellous bone volume in ovariectomized mice.
Shaughnessy SG; Walton KJ; Deschamps P; Butcher M; Beaudin SM
Cytokine; 2002 Oct; 20(2):78-85. PubMed ID: 12445802
[TBL] [Abstract][Full Text] [Related]
22. Persistent bone-sparing effect of interleukin-1 receptor antagonist: a hypothesis on the role of IL-1 in ovariectomy-induced bone loss.
Kimble RB; Kitazawa R; Vannice JL; Pacifici R
Calcif Tissue Int; 1994 Oct; 55(4):260-5. PubMed ID: 7820776
[TBL] [Abstract][Full Text] [Related]
23. IL-11 receptor alpha in the pathogenesis of IL-13-induced inflammation and remodeling.
Chen Q; Rabach L; Noble P; Zheng T; Lee CG; Homer RJ; Elias JA
J Immunol; 2005 Feb; 174(4):2305-13. PubMed ID: 15699166
[TBL] [Abstract][Full Text] [Related]
24. Estrogen regulates the production of VEGF for osteoclast formation and activity in op/op mice.
Kodama I; Niida S; Sanada M; Yoshiko Y; Tsuda M; Maeda N; Ohama K
J Bone Miner Res; 2004 Feb; 19(2):200-6. PubMed ID: 14969389
[TBL] [Abstract][Full Text] [Related]
25. Defective production of interleukin-11 by decidua and chorionic villi in human anembryonic pregnancy.
Chen HF; Lin CY; Chao KH; Wu MY; Yang YS; Ho HN
J Clin Endocrinol Metab; 2002 May; 87(5):2320-8. PubMed ID: 11994383
[TBL] [Abstract][Full Text] [Related]
26. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor.
Bellido T; Jilka RL; Boyce BF; Girasole G; Broxmeyer H; Dalrymple SA; Murray R; Manolagas SC
J Clin Invest; 1995 Jun; 95(6):2886-95. PubMed ID: 7769130
[TBL] [Abstract][Full Text] [Related]
27. gp130 signaling in bone cell biology: multiple roles revealed by analysis of genetically altered mice.
Sims NA
Mol Cell Endocrinol; 2009 Oct; 310(1-2):30-9. PubMed ID: 18805458
[TBL] [Abstract][Full Text] [Related]
28. Mice lacking the integrin beta5 subunit have accelerated osteoclast maturation and increased activity in the estrogen-deficient state.
Lane NE; Yao W; Nakamura MC; Humphrey MB; Kimmel D; Huang X; Sheppard D; Ross FP; Teitelbaum SL
J Bone Miner Res; 2005 Jan; 20(1):58-66. PubMed ID: 15619670
[TBL] [Abstract][Full Text] [Related]
29. IL-6 trans-signalling mediates trabecular, but not cortical, bone loss after ovariectomy.
Lazzaro L; Tonkin BA; Poulton IJ; McGregor NE; Ferlin W; Sims NA
Bone; 2018 Jul; 112():120-127. PubMed ID: 29679733
[TBL] [Abstract][Full Text] [Related]
30. Prevention of trabecular bone loss induced by estrogen deficiency by a selective p38alpha inhibitor.
Caverzasio J; Higgins L; Ammann P
J Bone Miner Res; 2008 Sep; 23(9):1389-97. PubMed ID: 18442314
[TBL] [Abstract][Full Text] [Related]
31. The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice.
Kimble RB; Bain S; Pacifici R
J Bone Miner Res; 1997 Jun; 12(6):935-41. PubMed ID: 9169353
[TBL] [Abstract][Full Text] [Related]
32. Estrogen receptor-α in osteocytes is important for trabecular bone formation in male mice.
Windahl SH; Börjesson AE; Farman HH; Engdahl C; Movérare-Skrtic S; Sjögren K; Lagerquist MK; Kindblom JM; Koskela A; Tuukkanen J; Divieti Pajevic P; Feng JQ; Dahlman-Wright K; Antonson P; Gustafsson JÅ; Ohlsson C
Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2294-9. PubMed ID: 23345419
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-11 signaling is required for the differentiation of natural killer cells at the maternal-fetal interface.
Ain R; Trinh ML; Soares MJ
Dev Dyn; 2004 Dec; 231(4):700-8. PubMed ID: 15499555
[TBL] [Abstract][Full Text] [Related]
34. Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency.
Miyaura C; Onoe Y; Inada M; Maki K; Ikuta K; Ito M; Suda T
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9360-5. PubMed ID: 9256487
[TBL] [Abstract][Full Text] [Related]
35. Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis.
Jenkins BJ; Roberts AW; Greenhill CJ; Najdovska M; Lundgren-May T; Robb L; Grail D; Ernst M
Blood; 2007 Mar; 109(6):2380-8. PubMed ID: 17082315
[TBL] [Abstract][Full Text] [Related]
36. Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways.
Sims NA; Jenkins BJ; Quinn JM; Nakamura A; Glatt M; Gillespie MT; Ernst M; Martin TJ
J Clin Invest; 2004 Feb; 113(3):379-89. PubMed ID: 14755335
[TBL] [Abstract][Full Text] [Related]
37. Differential transcriptional effects of PTH and estrogen during anabolic bone formation.
von Stechow D; Zurakowski D; Pettit AR; Müller R; Gronowicz G; Chorev M; Otu H; Libermann T; Alexander JM
J Cell Biochem; 2004 Oct; 93(3):476-90. PubMed ID: 15372627
[TBL] [Abstract][Full Text] [Related]
38. Physiological function of the angiotensin AT1a receptor in bone remodeling.
Kaneko K; Ito M; Fumoto T; Fukuhara R; Ishida J; Fukamizu A; Ikeda K
J Bone Miner Res; 2011 Dec; 26(12):2959-66. PubMed ID: 21887703
[TBL] [Abstract][Full Text] [Related]
39. Reduced bone turnover in mice lacking the P2Y13 receptor of ADP.
Wang N; Robaye B; Agrawal A; Skerry TM; Boeynaems JM; Gartland A
Mol Endocrinol; 2012 Jan; 26(1):142-52. PubMed ID: 22108801
[TBL] [Abstract][Full Text] [Related]
40. Genetic manipulation of the ghrelin signaling system in male mice reveals bone compartment specificity of acylated and unacylated ghrelin in the regulation of bone remodeling.
Delhanty PJ; van der Velde M; van der Eerden BC; Sun Y; Geminn JM; van der Lely AJ; Smith RG; van Leeuwen JP
Endocrinology; 2014 Nov; 155(11):4287-95. PubMed ID: 25060361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
